Simultaneous
photodynamic/photothermal therapy (PDT/PTT) is a combination
cancer treatment that combines the principles of both PDT and PTT
to achieve an effective and comprehensive attack on cancer cells.
However, both approaches require an external light source to generate
reactive oxygen species (ROS) and thermal heat, which could potentially
hinder the therapeutic efficacy due to the low tissue penetration
of light in vivo. Chemodynamic therapy (CDT) is a type of therapy
that uses the ROS generated by the chemical reaction between a prodrug
and a catalyst to kill cancer cells. We developed a combination therapy
of three modalities (PTT/PDT/CDT) using the metal-organic framework
(MOF). The Cu2+-doped MOF PCN-224 nanostructures modified
with platinum (Pt) cluster and folic acid (FA) provided excellent
tumor targeting, photothermal conversion ability, and ROS generated
by the Pt cluster and Cu2+ under 650 nm light irradiation.
Moreover, this multimodel nanocomposite had an extremely low dark
toxicity but excellent phototoxicity under the combination laser irradiation
at 650 nm, both in vitro and in vivo. Therefore, our prepared folic acid-conjugated PCN-224/Pt/Cu2+ (FA-PPC) nanosphere could be applied as a very promising
multimodal phototherapeutic agent for enhanced cancer therapy in future
clinical applications